Genmab Ownership 2024 | Who Owns Genmab Now?
Institutional Ownership
8.54%
Insider Ownership
0.01%
Retail Ownership
91.45%
Institutional Holders
99.00
Genmab Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALLIANCEBERNSTEIN L.P. | 23.33% | 0.13% | 15,237,839 | -16,508 | -0.11% | 382,926,894 | Jun 30, 2024 |
| BLACKROCK INC. | 7.78% | 0.00% | 5,080,562 | 13,429 | 0.27% | 127,674,528 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 6.47% | 0.02% | 4,227,965 | -145,312 | -3.32% | 108,151,240 | Jun 30, 2024 |
| HARDING LOEVNER LP | 4.24% | 0.38% | 2,767,805 | -526,923 | -15.99% | 69,605,254 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.53% | 0.01% | 2,306,920 | -24,894 | -1.07% | 57,972,899 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.24% | 0.06% | 1,462,459 | 103,859 | 7.64% | 36,751,595 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 1.85% | 0.03% | 1,208,973 | -20,597 | -1.68% | 30,381,491 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.68% | 0.00% | 1,097,271 | 14,724 | 1.36% | 27,574,419 | Jun 30, 2024 |
| MORGAN STANLEY | 1.58% | 0.00% | 1,029,377 | 55,341 | 5.68% | 25,868,282 | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 1.52% | 0.01% | 995,667 | -26,463 | -2.59% | 25,021,118 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.34% | 0.00% | 877,852 | 222,506 | 33.95% | 22,060,429 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 1.21% | 0.00% | 792,754 | 8,382 | 1.07% | 19,922,000 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 1.11% | 0.00% | 723,505 | -22,972 | -3.08% | 18,181,680 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.09% | 0.04% | 709,581 | 458,855 | 183.01% | 17,831,771 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.99% | 0.02% | 648,379 | -301,046 | -31.71% | 16,293,764 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.81% | 0.05% | 528,229 | 121,549 | 29.89% | 13,274,395 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.80% | 0.00% | 519,384 | -34,844 | -6.29% | 13,052,120,000 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.69% | 0.01% | 452,195 | -12,747 | -2.74% | 11,363,660 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.58% | 0.00% | 380,995 | -92,934 | -19.61% | 9,574,404 | Jun 30, 2024 |
| DDD PARTNERS, LLC | 0.54% | 1.03% | 352,569 | 352,569 | 100.00% | 8,860,059 | Jun 30, 2024 |
Genmab's largest institutional shareholder is ALLIANCEBERNSTEIN L.P., holding 23.33% of the company's total share outstanding, currently valued at $382.93M. The top 10 institutional shareholders own together 54.23% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DDD PARTNERS, LLC | 0.54% | 1.03% | 352,569 | 352,569 | 100.00% | 8,860,059 | Jun 30, 2024 |
| HARDING LOEVNER LP | 4.24% | 0.38% | 2,767,805 | -526,923 | -15.99% | 69,605,254 | Jun 30, 2024 |
| LEGACY WEALTH ASSET MANAGEMENT, LLC | 0.07% | 0.32% | 44,508 | 7,805 | 21.27% | 1,118,486 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.15% | 0.26% | 100,000 | - | - | 2,513,000 | Jun 30, 2024 |
| INGALLS & SNYDER LLC | 0.35% | 0.25% | 229,700 | 52,117 | 29.35% | 5,772,000 | Jun 30, 2024 |
| HARDMAN JOHNSTON GLOBAL ADVISORS LLC | 0.36% | 0.23% | 234,222 | -28,267 | -10.77% | 5,885,999 | Jun 30, 2024 |
| GALLACHER CAPITAL MANAGEMENT LLC | 0.02% | 0.16% | 11,958 | 4,093 | 52.04% | 300,505 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 23.33% | 0.13% | 15,237,839 | -16,508 | -0.11% | 382,926,894 | Jun 30, 2024 |
| FOLKETRYGDFONDET | 0.26% | 0.08% | 170,385 | - | - | 4,281,775 | Jun 30, 2024 |
| MAROTTA ASSET MANAGEMENT | 0.02% | 0.07% | 13,643 | -1,399 | -9.30% | 339,029 | Jun 30, 2024 |
| OPPENHEIMER ASSET MANAGEMENT INC. | 0.33% | 0.07% | 218,078 | 45,376 | 26.27% | 5,480,300 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.24% | 0.06% | 1,462,459 | 103,859 | 7.64% | 36,751,595 | Jun 30, 2024 |
| NEWEDGE WEALTH, LLC | 0.17% | 0.06% | 112,439 | 11,832 | 11.76% | 2,825,592 | Jun 30, 2024 |
| ONE WEALTH ADVISORS, LLC | 0.02% | 0.06% | 10,274 | 253 | 2.52% | 271,542 | Jun 30, 2024 |
| LVW ADVISORS, LLC | 0.02% | 0.05% | 14,606 | -181 | -1.22% | 367,049 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.81% | 0.05% | 528,229 | 121,549 | 29.89% | 13,274,395 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.02% | 0.05% | 10,053 | 10,053 | 100.00% | 252,632 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.43% | 0.05% | 278,541 | 145,689 | 109.66% | 6,999,726 | Jun 30, 2024 |
| GRANDFIELD & DODD, LLC | 0.04% | 0.04% | 25,753 | -665 | -2.52% | 647,173 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.09% | 0.04% | 709,581 | 458,855 | 183.01% | 17,831,771 | Jun 30, 2024 |
The largest Genmab shareholder by % of total assets is DDD PARTNERS, LLC. The company owns 352.57K shares of Genmab (GMAB), representing 1.03% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | 1.09% | 0.04% | 709,581 | 458,855 | 183.01% | 17,831,771 | Jun 30, 2024 |
| DDD PARTNERS, LLC | 0.54% | 1.03% | 352,569 | 352,569 | 100.00% | 8,860,059 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.34% | 0.00% | 877,852 | 222,506 | 33.95% | 22,060,429 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.41% | 0.03% | 265,000 | 175,000 | 194.44% | 6,659,450 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.43% | 0.05% | 278,541 | 145,689 | 109.66% | 6,999,726 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.81% | 0.05% | 528,229 | 121,549 | 29.89% | 13,274,395 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.24% | 0.06% | 1,462,459 | 103,859 | 7.64% | 36,751,595 | Jun 30, 2024 |
| MORGAN STANLEY | 1.58% | 0.00% | 1,029,377 | 55,341 | 5.68% | 25,868,282 | Jun 30, 2024 |
| INGALLS & SNYDER LLC | 0.35% | 0.25% | 229,700 | 52,117 | 29.35% | 5,772,000 | Jun 30, 2024 |
| OPPENHEIMER ASSET MANAGEMENT INC. | 0.33% | 0.07% | 218,078 | 45,376 | 26.27% | 5,480,300 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.06% | 0.00% | 37,409 | 37,409 | 100.00% | 940,000 | Jun 30, 2024 |
| CHOREO, LLC | 0.05% | 0.01% | 31,200 | 31,200 | 100.00% | 775,597 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.06% | 0.00% | 38,010 | 29,762 | 360.84% | 954,000 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.01% | 32,426 | 28,212 | 669.48% | 814,865 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.04% | 0.03% | 27,600 | 27,600 | 100.00% | 693,588 | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | 0.06% | 0.04% | 38,554 | 26,246 | 213.24% | 968,862 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.04% | 0.01% | 23,691 | 23,691 | 100.00% | 595,355 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.03% | 0.00% | 18,184 | 18,184 | 100.00% | 456,975 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.03% | 0.01% | 17,015 | 17,015 | 100.00% | 427,587 | Jun 30, 2024 |
| BAMCO INC /NY/ | 0.13% | 0.01% | 87,153 | 14,922 | 20.66% | 2,190,155 | Jun 30, 2024 |
As of Jun 30 2024, Genmab's largest institutional buyer is TWO SIGMA INVESTMENTS, LP. The company purchased 458.86K stocks of GMAB, valued at $17.83M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HARDING LOEVNER LP | 4.24% | 0.38% | 2,767,805 | -526,923 | -15.99% | 69,605,254 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.99% | 0.02% | 648,379 | -301,046 | -31.71% | 16,293,764 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | - | - | - | -242,385 | -100.00% | - | Jun 30, 2024 |
| ROYAL LONDON ASSET MANAGEMENT LTD | 0.08% | 0.00% | 49,849 | -175,556 | -77.88% | 1,252,705 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 6.47% | 0.02% | 4,227,965 | -145,312 | -3.32% | 108,151,240 | Jun 30, 2024 |
| FMR LLC | 0.38% | 0.00% | 245,118 | -129,289 | -34.53% | 6,159,827 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.18% | 0.00% | 114,523 | -123,433 | -51.87% | 2,877,963 | Jun 30, 2024 |
| TORRAY INVESTMENT PARTNERS LLC | - | - | - | -107,934 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.58% | 0.00% | 380,995 | -92,934 | -19.61% | 9,574,404 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -85,200 | -100.00% | - | Jun 30, 2024 |
| SYNOVUS FINANCIAL CORP | - | - | - | -82,858 | -100.00% | - | Jun 30, 2024 |
| NATIXIS ADVISORS, L.P. | 0.24% | 0.01% | 159,126 | -76,848 | -32.57% | 3,999,000 | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -61,005 | -100.00% | - | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.27% | 0.00% | 174,927 | -58,001 | -24.90% | 4,395,907 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.02% | 0.00% | 11,513 | -55,600 | -82.85% | 289,322 | Jun 30, 2024 |
| ABRDN PLC | - | - | - | -49,797 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.80% | 0.00% | 519,384 | -34,844 | -6.29% | 13,052,120,000 | Jun 30, 2024 |
| HARDMAN JOHNSTON GLOBAL ADVISORS LLC | 0.36% | 0.23% | 234,222 | -28,267 | -10.77% | 5,885,999 | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 1.52% | 0.01% | 995,667 | -26,463 | -2.59% | 25,021,118 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.53% | 0.01% | 2,306,920 | -24,894 | -1.07% | 57,972,899 | Jun 30, 2024 |
As of Jun 30 2024, Genmab's biggest institutional seller is HARDING LOEVNER LP. The company sold -0.53M shares of GMAB, valued at $69.61M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DDD PARTNERS, LLC | 0.54% | 1.03% | 352,569 | 352,569 | 100.00% | 8,860,059 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.06% | 0.00% | 37,409 | 37,409 | 100.00% | 940,000 | Jun 30, 2024 |
| CHOREO, LLC | 0.05% | 0.01% | 31,200 | 31,200 | 100.00% | 775,597 | Jun 30, 2024 |
| GREENLEAF TRUST | 0.02% | 0.00% | 13,230 | 13,230 | 100.00% | 332,470 | Jun 30, 2024 |
| CI PRIVATE WEALTH, LLC | 0.02% | 0.00% | 10,483 | 10,483 | 100.00% | 263,439 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.02% | 0.00% | 10,351 | 10,351 | 100.00% | 260,000 | Jun 30, 2024 |
| GLENMEDE TRUST CO NA | 0.01% | 0.00% | 8,698 | 8,698 | 100.00% | 218,580 | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | 0.01% | 0.00% | 8,189 | 8,189 | 100.00% | 205,790 | Jun 30, 2024 |
| 0.00% | 0.01% | 380 | 380 | 100.00% | 9,549 | Jun 30, 2024 | |
| WEALTHCOLLAB, LLC | 0.00% | 0.01% | 291 | 291 | 100.00% | 7,313 | Jun 30, 2024 |
| POINT72 HONG KONG LTD | 0.00% | 0.00% | 234 | 234 | 100.00% | 5,889 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.00% | 202 | 202 | 100.00% | 5,076 | Jun 30, 2024 |
| WHITTIER TRUST CO | 0.00% | - | 110 | 110 | 100.00% | 2,763 | Jun 30, 2024 |
| CREEKMUR ASSET MANAGEMENT LLC | 0.00% | 0.00% | 79 | 79 | 100.00% | 1,985 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.00% | 0.00% | 77 | 77 | 100.00% | 1,924 | Jun 30, 2024 |
| OPAL WEALTH ADVISORS, LLC | - | 0.00% | 30 | 30 | 100.00% | 754 | Jun 30, 2024 |
| LYNX INVESTMENT ADVISORY | - | 0.00% | 21 | 21 | 100.00% | 528,000 | Jun 30, 2024 |
Genmab's largest new institutional shareholder by number of shares is DDD PARTNERS, LLC, purchased 352.57K shares, valued at $8.86M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | - | - | - | -242,385 | -100.00% | - | Jun 30, 2024 |
| TORRAY INVESTMENT PARTNERS LLC | - | - | - | -107,934 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -85,200 | -100.00% | - | Jun 30, 2024 |
| SYNOVUS FINANCIAL CORP | - | - | - | -82,858 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -61,005 | -100.00% | - | Jun 30, 2024 |
| ABRDN PLC | - | - | - | -49,797 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -21,905 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -19,116 | -100.00% | - | Jun 30, 2024 |
| DYNASTY WEALTH MANAGEMENT, LLC | - | - | - | -13,472 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -13,015 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -11,436 | -100.00% | - | Jun 30, 2024 |
| SCHECHTER INVESTMENT ADVISORS, LLC | - | - | - | -11,289 | -100.00% | - | Jun 30, 2024 |
| TEAM HEWINS, LLC | - | - | - | -11,058 | -100.00% | - | Jun 30, 2024 |
| BAROMETER CAPITAL MANAGEMENT INC. | - | - | - | -10,337 | -100.00% | - | Jun 30, 2024 |
| ARGENT TRUST CO | - | - | - | -9,638 | -100.00% | - | Jun 30, 2024 |
| MOUNT YALE INVESTMENT ADVISORS, LLC | - | - | - | -9,113 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -8,800 | -100.00% | - | Jun 30, 2024 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | - | - | - | -8,511 | -100.00% | - | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -7,682 | -100.00% | - | Jun 30, 2024 |
| KNOLLWOOD INVESTMENT ADVISORY, LLC | - | - | - | -7,300 | -100.00% | - | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -6,996 | -100.00% | - | Jun 30, 2024 |
| REGAL INVESTMENT ADVISORS LLC | - | - | - | -6,863 | -100.00% | - | Jun 30, 2024 |
| SNOWDEN CAPITAL ADVISORS LLC | - | - | - | -6,861 | -100.00% | - | Jun 30, 2024 |
| THOMPSON DAVIS & CO., INC. | - | - | - | -6,750 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -5,673 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -1,225 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -951 | -100.00% | - | Jun 30, 2024 |
| JANICZEK WEALTH MANAGEMENT, LLC | - | - | - | -370 | -100.00% | - | Jun 30, 2024 |
| BESSEMER GROUP INC | - | - | - | -185 | -100.00% | - | Jun 30, 2024 |
| CEDAR WEALTH MANAGEMENT, LLC | - | - | - | -64 | -100.00% | - | Jun 30, 2024 |
| SANCTUARY WEALTH MANAGEMENT, L.L.C. | - | - | - | -35 | -100.00% | - | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | - | - | - | -33 | -100.00% | - | Jun 30, 2024 |
| ADVISORNET FINANCIAL, INC | - | - | - | -32 | -100.00% | - | Jun 30, 2024 |
| CLARIVEST ASSET MANAGEMENT LLC | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Genmab's largest sold out institutional shareholder by shares sold is SCHRODER INVESTMENT MANAGEMENT GROUP, sold -0.24M shares, valued at -, as of undefined.
Genmab Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SPARROW FUNDS | 1.58% | 5,635 | - | - | Feb 29, 2024 |
| AB CORE OPPORTUNITIES FUND, INC. | 0.98% | 48,425 | -37,289 | -43.50% | Feb 29, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.38% | 447,643 | - | - | Mar 28, 2024 |
| PRUDENTIAL JENNISON MID-CAP GROWTH FUND, INC. | 0.34% | 694,664 | - | - | Feb 29, 2024 |
| AB LARGE CAP GROWTH FUND INC | 0.34% | 4,451,787 | 388,461 | 9.56% | Jan 31, 2024 |
| Tema ETF Trust | 0.27% | 12,127 | 181 | 1.52% | Feb 29, 2024 |
| ALGER FUNDS | 0.25% | 242,874 | - | - | Jan 31, 2024 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.24% | 22,588 | - | - | Feb 29, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.19% | 49,006 | - | - | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.19% | 385,410 | - | - | Feb 29, 2024 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.19% | 64,577 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.12% | 1,222,705 | -41,712 | -3.30% | Mar 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.11% | 105,821 | - | - | Feb 29, 2024 |
| ALGER FUNDS II | 0.09% | 20,191 | - | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust | 0.08% | 19,943 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.06% | 29,963 | - | - | Mar 31, 2024 |
| Tekla Healthcare Opportunities Fund | 0.06% | 131,628 | - | - | Mar 31, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.06% | 3,150,246 | - | - | Jan 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.05% | 43,052 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.04% | 114,086 | - | - | Mar 31, 2024 |
| Tekla World Healthcare Fund | 0.04% | 49,797 | 49,797 | - | Mar 31, 2024 |
| Manager Directed Portfolios | 0.03% | 5,510 | - | - | Jan 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.03% | 147,067 | 1,469 | 1.01% | Mar 31, 2024 |
| Starboard Investment Trust | 0.03% | 15,100 | - | - | Feb 29, 2024 |
| Federated Hermes Equity Funds | 0.03% | 502,834 | - | - | Jan 31, 2024 |
| AB PORTFOLIOS | 0.02% | 464,310 | -26,150 | -5.33% | Jan 31, 2024 |
| ALGER PORTFOLIOS | 0.02% | 8,622 | - | - | Dec 31, 2023 |
| AZZAD FUNDS | 0.02% | 47,713 | - | - | Mar 31, 2024 |
| Federated Hermes Adviser Series | 0.02% | 125,263 | - | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.02% | 76,565 | - | - | Jan 31, 2024 |
| STEWARD FUNDS, INC. | 0.01% | 35,528 | -4,511 | -11.27% | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.01% | 45,647 | - | - | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.01% | 185,883 | - | - | Dec 31, 2023 |
| Ivy Variable Insurance Portfolios | 0.01% | 163,574 | - | - | Mar 28, 2024 |
| BARON SELECT FUNDS | 0.01% | 72,231 | -66,714 | -48.01% | Mar 31, 2024 |
| AdvisorShares Trust | 0.01% | 25,185 | - | - | Mar 28, 2024 |
| IVY FUNDS | 0.01% | 1,976,731 | - | - | Mar 28, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 15,943 | 248 | 1.58% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 10,329 | - | - | Mar 31, 2024 |
| DOMINI INVESTMENT TRUST | 0.00% | 21,600 | - | - | Jan 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 14,700 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 54,010 | 28,144 | 108.81% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 10,729 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 48,287 | -4,533 | -8.58% | Mar 31, 2024 |
| AMERICAN PENSION INVESTORS TRUST | 0.00% | 10,100 | -6,500 | -39.16% | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 270,739 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 48,187 | - | - | Mar 28, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 2,100 | - | - | Mar 31, 2024 |
| GLENMEDE FUND INC | 0.00% | 11,009 | - | - | Jan 31, 2024 |
| Franklin Custodian Funds | 0.00% | 500,000 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 108,077 | 7,038 | 6.97% | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 328,471 | 23,353 | 7.65% | Jan 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 8,040 | - | - | Mar 28, 2024 |
| Listed Funds Trust | 0.00% | 4,069 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 2,656 | - | - | Mar 28, 2024 |
| LORD ABBETT SERIES FUND INC | 0.00% | 37,942 | - | - | Mar 31, 2024 |
| LORD ABBETT BOND DEBENTURE FUND INC | 0.00% | 501,788 | - | - | Mar 31, 2024 |
| Voya PARTNERS INC | 0.00% | 33,400 | - | - | Mar 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 5,000 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 2,189 | - | - | Mar 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 38,800 | - | - | Jan 31, 2024 |
| Advisors Preferred Trust | 0.00% | 2,563 | - | - | Mar 31, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 2,393 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 21,490 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 337,039 | - | - | Mar 31, 2024 |
| TRANSAMERICA SERIES TRUST | 0.00% | 270,516 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND II | 0.00% | 1,983 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 4,228,412 | 643,468 | 17.95% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 189 | 7 | 3.85% | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 4,341 | 693 | 19.00% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 81,292 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 40,940 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 27,016 | 1,375 | 5.36% | Feb 29, 2024 |
| Franklin Global Trust | 0.00% | 40,000 | - | - | Jan 31, 2024 |
| Pacer Funds Trust | 0.00% | 5,810 | - | - | Jan 31, 2024 |
| Guardian Variable Products Trust | 0.00% | 1,782 | - | - | Mar 31, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 33,672 | 19,817 | 143.03% | Feb 29, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 362,225 | - | - | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 8,464 | - | - | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 225,682 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 6,690 | -4,937 | -42.46% | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 1,516 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 139,867 | -49,502 | -26.14% | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 289,405 | - | - | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 12,784 | 5,201 | 68.59% | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 129,533 | - | - | Mar 31, 2024 |
| LORD ABBETT TRUST I | 0.00% | 823 | - | - | Jan 31, 2024 |
| Northern Lights Fund Trust IV | 0.00% | 8,405 | - | - | Jan 31, 2024 |
| RBB FUND, INC. | 0.00% | 2,330 | - | - | Feb 29, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 13,614 | - | - | Feb 29, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 77,143 | - | - | Mar 28, 2024 |
| PROSHARES TRUST | 0.00% | 3,133 | 458 | 17.12% | Feb 29, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 13,417 | - | - | Feb 29, 2024 |
| AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.00% | 154,335 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 8,623 | - | - | Mar 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 21,685 | - | - | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 28 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 13,702 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,102 | 367 | 49.93% | Feb 29, 2024 |
| Brighthouse Funds Trust I | 0.00% | 27,077 | - | - | Mar 31, 2024 |
Genmab's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 5.63K shares, compromising 1.58% of its total assets.
Genmab Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 99 | -56.96% |
| 31 Mar, 24 | 230 | 2.68% |
| 31 Dec, 23 | 224 | -3.86% |
| 30 Sep, 23 | 233 | 10.43% |
| 30 Jun, 23 | 211 | -1.40% |
| 31 Mar, 23 | 214 | -8.94% |
| 31 Dec, 22 | 235 | 22.40% |
| 30 Sep, 22 | 192 | 9.09% |
| 30 Jun, 22 | 176 | -12.44% |
| 31 Mar, 22 | 201 | -3.83% |
| 31 Dec, 21 | 209 | -1.42% |
| 30 Sep, 21 | 212 | -1.40% |
| 30 Jun, 21 | 215 | 2.87% |
| 31 Mar, 21 | 209 | -6.70% |
| 31 Dec, 20 | 224 | 11.44% |
| 30 Sep, 20 | 201 | 14.20% |
| 30 Jun, 20 | 176 | 25.71% |
| 31 Mar, 20 | 140 | 9.38% |
| 31 Dec, 19 | 128 | 33.33% |
| 30 Sep, 19 | 96 | 1271.43% |
| 30 Jun, 19 | 7 | -12.50% |
| 31 Mar, 19 | 8 | 33.33% |
| 31 Dec, 18 | 6 | - |
| 30 Sep, 18 | 6 | - |
| 30 Jun, 18 | 6 | 20.00% |
| 31 Mar, 18 | 5 | 25.00% |
| 31 Dec, 17 | 4 | -20.00% |
| 30 Sep, 17 | 5 | 25.00% |
| 30 Jun, 17 | 4 | 33.33% |
| 31 Mar, 17 | 3 | 50.00% |
| 31 Dec, 16 | 2 | 100.00% |
| 30 Sep, 16 | 1 | - |
| 30 Jun, 16 | 1 | - |
| 30 Sep, 14 | 1 | - |
| 30 Jun, 14 | 1 | - |
| 31 Mar, 14 | 1 | - |
| 31 Mar, 10 | 1 | - |
As of 30 Jun 24, 99 institutions are holding Genmab's shares, representing a decrease of -56.96% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 5,576,330 | -88.35% |
| 31 Mar, 24 | 47,860,397 | 2.68% |
| 31 Dec, 23 | 46,612,391 | -1.69% |
| 30 Sep, 23 | 47,412,406 | 13.83% |
| 30 Jun, 23 | 41,650,174 | -4.31% |
| 31 Mar, 23 | 43,524,207 | -4.85% |
| 31 Dec, 22 | 45,741,668 | 3.04% |
| 30 Sep, 22 | 44,390,423 | 24.95% |
| 30 Jun, 22 | 35,527,584 | -9.04% |
| 31 Mar, 22 | 39,056,720 | -1.78% |
| 31 Dec, 21 | 39,762,823 | -6.99% |
| 30 Sep, 21 | 42,750,141 | -7.39% |
| 30 Jun, 21 | 46,162,221 | 10.38% |
| 31 Mar, 21 | 41,820,161 | -0.93% |
| 31 Dec, 20 | 42,212,482 | 3.15% |
| 30 Sep, 20 | 40,924,459 | 7.86% |
| 30 Jun, 20 | 37,940,678 | 33.04% |
| 31 Mar, 20 | 28,517,341 | 19.86% |
| 31 Dec, 19 | 23,792,305 | -5.95% |
| 30 Sep, 19 | 25,298,831 | 2211.77% |
| 30 Jun, 19 | 1,094,347 | 4.58% |
| 31 Mar, 19 | 1,046,385 | 205.21% |
| 31 Dec, 18 | 342,843 | 8.58% |
| 30 Sep, 18 | 315,759 | -27.87% |
| 30 Jun, 18 | 437,761 | 415.98% |
| 31 Mar, 18 | 84,840 | 88.20% |
| 31 Dec, 17 | 45,079 | 4.41% |
| 30 Sep, 17 | 43,176 | 19.09% |
| 30 Jun, 17 | 36,255 | 50.09% |
| 31 Mar, 17 | 24,155 | 31.73% |
| 31 Dec, 16 | 18,337 | 459.40% |
| 30 Sep, 16 | 3,278 | -14.46% |
| 30 Jun, 16 | 3,832 | - |
| 30 Sep, 14 | 445 | 256.00% |
| 30 Jun, 14 | 125 | 7.76% |
| 31 Mar, 14 | 116 | - |
| 31 Mar, 10 | 35 | - |
Genmab (GMAB) has 5.58M shares outstanding as of 30 Jun 24, down -88.35% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 8.54% | 0.16% |
| 31 Mar, 24 | 73.26% | 143.80% |
| 31 Dec, 23 | 7.14% | 13.51% |
| 30 Sep, 23 | 7.27% | 18.24% |
| 30 Jun, 23 | 6.31% | 14.51% |
| 31 Mar, 23 | 6.60% | 13.48% |
| 31 Dec, 22 | 7.00% | 15.13% |
| 30 Sep, 22 | 6.80% | 23.11% |
| 30 Jun, 22 | 5.42% | 15.25% |
| 31 Mar, 22 | 5.96% | 16.13% |
| 31 Dec, 21 | 6.08% | 14.23% |
| 30 Sep, 21 | 6.54% | 13.12% |
| 30 Jun, 21 | 7.06% | 17.26% |
| 31 Mar, 21 | 6.40% | 15.25% |
| 31 Dec, 20 | 6.48% | 16.43% |
| 30 Sep, 20 | 6.28% | 18.49% |
| 30 Jun, 20 | 5.83% | 30.40% |
| 31 Mar, 20 | 4.38% | 31.77% |
| 31 Dec, 19 | 3.71% | 23.82% |
| 30 Sep, 19 | 3.95% | 12472.51% |
| 30 Jun, 19 | 0.18% | 608.42% |
| 31 Mar, 19 | 0.17% | 5456.79% |
| 31 Dec, 18 | 0.06% | 2111.46% |
| 30 Sep, 18 | 0.05% | 1004.05% |
| 30 Jun, 18 | 0.07% | 1485.59% |
| 31 Mar, 18 | 0.07% | 5446.22% |
| 31 Dec, 17 | 0.04% | 3052.92% |
| 30 Sep, 17 | 0.03% | 3852.01% |
| 30 Jun, 17 | 0.03% | 7245.81% |
| 31 Mar, 17 | 0.02% | 8661.44% |
| 31 Dec, 16 | 0.02% | 207185.19% |
| 30 Sep, 16 | 0.00% | 26584.38% |
| 30 Jun, 16 | 0.00% | - |
| 30 Sep, 14 | 0.00% | 3568700.00% |
| 30 Jun, 14 | 0.00% | 1043100.00% |
| 31 Mar, 14 | 0.00% | - |
| 31 Mar, 10 | - | - |
As of 30 Jun 24, Genmab is held by 8.54% institutional shareholders, representing a 0.16% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 42 | -67.69% |
| 31 Mar, 24 | 130 | 34.02% |
| 31 Dec, 23 | 97 | -29.20% |
| 30 Sep, 23 | 137 | 39.80% |
| 30 Jun, 23 | 98 | -2.00% |
| 31 Mar, 23 | 100 | -25.93% |
| 31 Dec, 22 | 135 | 19.47% |
| 30 Sep, 22 | 113 | 54.79% |
| 30 Jun, 22 | 73 | -23.96% |
| 31 Mar, 22 | 96 | -3.03% |
| 31 Dec, 21 | 99 | -19.51% |
| 30 Sep, 21 | 123 | -1.60% |
| 30 Jun, 21 | 125 | 12.61% |
| 31 Mar, 21 | 111 | -19.57% |
| 31 Dec, 20 | 138 | 12.20% |
| 30 Sep, 20 | 123 | 6.03% |
| 30 Jun, 20 | 116 | 45.00% |
| 31 Mar, 20 | 80 | -8.05% |
| 31 Dec, 19 | 87 | -7.45% |
| 30 Sep, 19 | 94 | 2250.00% |
| 30 Jun, 19 | 4 | -42.86% |
| 31 Mar, 19 | 7 | 75.00% |
| 31 Dec, 18 | 4 | 33.33% |
| 30 Sep, 18 | 3 | -50.00% |
| 30 Jun, 18 | 6 | 50.00% |
| 31 Mar, 18 | 4 | 100.00% |
| 31 Dec, 17 | 2 | -33.33% |
| 30 Sep, 17 | 3 | 50.00% |
| 30 Jun, 17 | 2 | - |
| 31 Mar, 17 | 2 | - |
| 31 Dec, 16 | 2 | - |
| 30 Sep, 16 | - | -100.00% |
| 30 Jun, 16 | 1 | - |
| 30 Sep, 14 | 1 | - |
| 30 Jun, 14 | 1 | - |
| 31 Mar, 14 | 1 | - |
| 31 Mar, 10 | 1 | - |
42 institutional shareholders have increased their position in GMAB stock as of 30 Jun 24 compared to 130 in the previous quarter (a -67.69% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 38 | -46.48% |
| 31 Mar, 24 | 71 | -29.00% |
| 31 Dec, 23 | 100 | 81.82% |
| 30 Sep, 23 | 55 | -31.25% |
| 30 Jun, 23 | 80 | -10.11% |
| 31 Mar, 23 | 89 | 9.88% |
| 31 Dec, 22 | 81 | 35.00% |
| 30 Sep, 22 | 60 | -24.05% |
| 30 Jun, 22 | 79 | -2.47% |
| 31 Mar, 22 | 81 | -2.41% |
| 31 Dec, 21 | 83 | 48.21% |
| 30 Sep, 21 | 56 | 1.82% |
| 30 Jun, 21 | 55 | -20.29% |
| 31 Mar, 21 | 69 | 18.97% |
| 31 Dec, 20 | 58 | 9.43% |
| 30 Sep, 20 | 53 | 26.19% |
| 30 Jun, 20 | 42 | -6.67% |
| 31 Mar, 20 | 45 | 66.67% |
| 31 Dec, 19 | 27 | - |
| 30 Sep, 19 | - | -100.00% |
| 30 Jun, 19 | 2 | - |
| 31 Mar, 19 | - | -100.00% |
| 31 Dec, 18 | 1 | -66.67% |
| 30 Sep, 18 | 3 | - |
| 30 Jun, 18 | - | -100.00% |
| 31 Mar, 18 | 1 | -50.00% |
| 31 Dec, 17 | 2 | 100.00% |
| 30 Sep, 17 | 1 | - |
| 30 Jun, 17 | 1 | - |
| 31 Mar, 17 | 1 | - |
| 31 Dec, 16 | - | -100.00% |
| 30 Sep, 16 | 1 | - |
| 30 Jun, 16 | - | - |
| 30 Sep, 14 | - | - |
| 30 Jun, 14 | - | - |
| 31 Mar, 14 | - | - |
| 31 Mar, 10 | - | - |
38 institutional shareholders have reduced their position in GMAB stock as of 30 Jun 24 compared to 71 in the previous quarter (a -46.48% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 99 | -56.96% | 5,576,330 | -88.35% | 8.54% | 0.16% | 42 | -67.69% | 38 | -46.48% |
| 31 Mar, 24 | 230 | 2.68% | 47,860,397 | 2.68% | 73.26% | 143.80% | 130 | 34.02% | 71 | -29.00% |
| 31 Dec, 23 | 224 | -3.86% | 46,612,391 | -1.69% | 7.14% | 13.51% | 97 | -29.20% | 100 | 81.82% |
| 30 Sep, 23 | 233 | 10.43% | 47,412,406 | 13.83% | 7.27% | 18.24% | 137 | 39.80% | 55 | -31.25% |
| 30 Jun, 23 | 211 | -1.40% | 41,650,174 | -4.31% | 6.31% | 14.51% | 98 | -2.00% | 80 | -10.11% |
| 31 Mar, 23 | 214 | -8.94% | 43,524,207 | -4.85% | 6.60% | 13.48% | 100 | -25.93% | 89 | 9.88% |
| 31 Dec, 22 | 235 | 22.40% | 45,741,668 | 3.04% | 7.00% | 15.13% | 135 | 19.47% | 81 | 35.00% |
| 30 Sep, 22 | 192 | 9.09% | 44,390,423 | 24.95% | 6.80% | 23.11% | 113 | 54.79% | 60 | -24.05% |
| 30 Jun, 22 | 176 | -12.44% | 35,527,584 | -9.04% | 5.42% | 15.25% | 73 | -23.96% | 79 | -2.47% |
| 31 Mar, 22 | 201 | -3.83% | 39,056,720 | -1.78% | 5.96% | 16.13% | 96 | -3.03% | 81 | -2.41% |
| 31 Dec, 21 | 209 | -1.42% | 39,762,823 | -6.99% | 6.08% | 14.23% | 99 | -19.51% | 83 | 48.21% |
| 30 Sep, 21 | 212 | -1.40% | 42,750,141 | -7.39% | 6.54% | 13.12% | 123 | -1.60% | 56 | 1.82% |
| 30 Jun, 21 | 215 | 2.87% | 46,162,221 | 10.38% | 7.06% | 17.26% | 125 | 12.61% | 55 | -20.29% |
| 31 Mar, 21 | 209 | -6.70% | 41,820,161 | -0.93% | 6.40% | 15.25% | 111 | -19.57% | 69 | 18.97% |
| 31 Dec, 20 | 224 | 11.44% | 42,212,482 | 3.15% | 6.48% | 16.43% | 138 | 12.20% | 58 | 9.43% |
| 30 Sep, 20 | 201 | 14.20% | 40,924,459 | 7.86% | 6.28% | 18.49% | 123 | 6.03% | 53 | 26.19% |
| 30 Jun, 20 | 176 | 25.71% | 37,940,678 | 33.04% | 5.83% | 30.40% | 116 | 45.00% | 42 | -6.67% |
| 31 Mar, 20 | 140 | 9.38% | 28,517,341 | 19.86% | 4.38% | 31.77% | 80 | -8.05% | 45 | 66.67% |
| 31 Dec, 19 | 128 | 33.33% | 23,792,305 | -5.95% | 3.71% | 23.82% | 87 | -7.45% | 27 | - |
| 30 Sep, 19 | 96 | 1271.43% | 25,298,831 | 2211.77% | 3.95% | 12472.51% | 94 | 2250.00% | - | -100.00% |
| 30 Jun, 19 | 7 | -12.50% | 1,094,347 | 4.58% | 0.18% | 608.42% | 4 | -42.86% | 2 | - |
| 31 Mar, 19 | 8 | 33.33% | 1,046,385 | 205.21% | 0.17% | 5456.79% | 7 | 75.00% | - | -100.00% |
| 31 Dec, 18 | 6 | - | 342,843 | 8.58% | 0.06% | 2111.46% | 4 | 33.33% | 1 | -66.67% |
| 30 Sep, 18 | 6 | - | 315,759 | -27.87% | 0.05% | 1004.05% | 3 | -50.00% | 3 | - |
| 30 Jun, 18 | 6 | 20.00% | 437,761 | 415.98% | 0.07% | 1485.59% | 6 | 50.00% | - | -100.00% |
| 31 Mar, 18 | 5 | 25.00% | 84,840 | 88.20% | 0.07% | 5446.22% | 4 | 100.00% | 1 | -50.00% |
| 31 Dec, 17 | 4 | -20.00% | 45,079 | 4.41% | 0.04% | 3052.92% | 2 | -33.33% | 2 | 100.00% |
| 30 Sep, 17 | 5 | 25.00% | 43,176 | 19.09% | 0.03% | 3852.01% | 3 | 50.00% | 1 | - |
| 30 Jun, 17 | 4 | 33.33% | 36,255 | 50.09% | 0.03% | 7245.81% | 2 | - | 1 | - |
| 31 Mar, 17 | 3 | 50.00% | 24,155 | 31.73% | 0.02% | 8661.44% | 2 | - | 1 | - |
| 31 Dec, 16 | 2 | 100.00% | 18,337 | 459.40% | 0.02% | 207185.19% | 2 | - | - | -100.00% |
| 30 Sep, 16 | 1 | - | 3,278 | -14.46% | 0.00% | 26584.38% | - | -100.00% | 1 | - |
| 30 Jun, 16 | 1 | - | 3,832 | - | 0.00% | - | 1 | - | - | - |
| 30 Sep, 14 | 1 | - | 445 | 256.00% | 0.00% | 3568700.00% | 1 | - | - | - |
| 30 Jun, 14 | 1 | - | 125 | 7.76% | 0.00% | 1043100.00% | 1 | - | - | - |
| 31 Mar, 14 | 1 | - | 116 | - | 0.00% | - | 1 | - | - | - |
| 31 Mar, 10 | 1 | - | 35 | - | - | - | 1 | - | - | - |
Genmab Peer Ownership
| Ticker | Company |
|---|---|
| AKRO | Akero Therapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| ALEC | Alector, Inc. |
| BGNE | BeiGene, Ltd. |
| TVTX | Travere Therapeutics, Inc. |
| LEGN | Legend Biotech Corporation |
| TERN | Terns Pharmaceuticals, Inc. |
| ASND | Ascendis Pharma A/S |
| PCVX | Vaxcyte, Inc. |
| CYTK | Cytokinetics, Incorporated |
| AMLX | Amylyx Pharmaceuticals, Inc. |
GMAB Ownership FAQ
Who Owns Genmab?
Genmab is owned by institutional shareholders (8.54%), insiders (0.01%), and public (91.45%). The largest institutional shareholder of Genmab is ALLIANCEBERNSTEIN L.P. (23.33% of total shares) and the top mutual fund owner is SPARROW FUNDS (1.58% of total shares).
Who are the major institutional shareholders of Genmab?
Genmab's major institutional shareholders are ALLIANCEBERNSTEIN L.P., BLACKROCK INC., CAPITAL INTERNATIONAL INVESTORS, HARDING LOEVNER LP, and WELLINGTON MANAGEMENT GROUP LLP. The top five shareholders own together 45.36% of the company's share outstanding.
How many Genmab shareholders are there?
As of Jun 2024, there are 99 institutional shareholders of Genmab.
What percentage of Genmab is owned by ALLIANCEBERNSTEIN L.P?
ALLIANCEBERNSTEIN L.P owns 15.24M shares of Genmab, representing 23.33% of the company's total shares outstanding, valued at $382.93M (as of Jun 2024).
What percentage of Genmab is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 5.08M shares of Genmab (GMAB), compromising 7.78% of the company, valued at $127.67M.
What percentage of Genmab is owned by CAPITAL INTERNATIONAL INVESTORS?
CAPITAL INTERNATIONAL INVESTORS is the third largest holder of Genmab. The company owns 4.23M of the company's shares outstanding (worth $108.15M).